quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:31:00·57d
PRRelease
20/20 Biolabs Inc. logo

20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities

AIDX· 20/20 Biolabs Inc.
Health Care
Original source

Companies

  • AIDX
    20/20 Biolabs Inc.
    Health Care

Related

  • SEC10d
    SEC Form 424B3 filed by 20/20 Biolabs Inc.
  • SEC10d
    SEC Form 424B3 filed by 20/20 Biolabs Inc.
  • SEC11d
    SEC Form EFFECT filed by 20/20 Biolabs Inc.
  • SEC14d
    SEC Form EFFECT filed by 20/20 Biolabs Inc.
  • PR16d
    20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
  • INSIDER17d
    SEC Form 4 filed by Bergman Alan B.
  • INSIDER17d
    SEC Form 4 filed by Zhou Jiming
  • SEC17d
    SEC Form S-1 filed by 20/20 Biolabs Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022